SCHEMBL20232116

SCHEMBL20232116

c1ccc(-c2ccc3c(c2)c2ccccc2c2ccccc2c2cc(-c4ccccc4)ccc2n3-c2nc(-c3ccc4c(c3)c3ccccc3n4-c3ccccc3)c3ccccc3n2)cc1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
L3MBTL1 Q9Y468 5/20 0.44
KDM4E B2RXH2 3/20 0.44
ATM Q13315 2/20 0.44
ALDH1A1 P00352 4/20 0.44
HPGD P15428 3/20 0.44
MAPT P10636 3/20 0.44
NPSR1 Q6W5P4 1/20 0.44
LMNA P02545 2/20 0.41
PTGER4 P35408 1/20 0.39
MAPK1 P28482 2/20 0.38
HTT P42858 2/20 0.38
POLB P06746 1/20 0.38
TDP1 Q9NUW8 1/20 0.38
MEN1 O00255 2/20 0.36
KMT2A Q03164 2/20 0.36
HSP90AA1 P07900 1/20 0.36
NPY5R Q15761 1/20 0.36
IL1R1 P14778 1/20 0.36
TSPO P30536 1/20 0.36
HDAC4 P56524 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16706368 0.96 L3MBTL1 (0.43) L3MBTL1KDM4EATMALDH1A1HPGD
SCHEMBL15537274 0.96 L3MBTL1 (0.43) L3MBTL1KDM4EATMALDH1A1HPGD
SCHEMBL15615518 0.96 L3MBTL1 (0.43) L3MBTL1KDM4EATMALDH1A1HPGD
SCHEMBL16475838 0.96 KDM4E (0.48) L3MBTL1KDM4EATMALDH1A1HPGD
SCHEMBL22479831 0.96 KDM4E (0.48) L3MBTL1KDM4EATMALDH1A1HPGD
SCHEMBL16475779 0.96 KDM4E (0.48) L3MBTL1KDM4EATMALDH1A1HPGD
SCHEMBL16475845 0.96 KDM4E (0.48) L3MBTL1KDM4EATMALDH1A1HPGD
SCHEMBL15583014 0.96 KDM4E (0.48) L3MBTL1KDM4EATMALDH1A1HPGD
SCHEMBL15638499 0.96 KDM4E (0.48) L3MBTL1KDM4EATMALDH1A1HPGD
SCHEMBL15197764 0.96 KDM4E (0.48) L3MBTL1KDM4EATMALDH1A1HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3548481-B1 HETEROCYCLIC COMPOUNDS FOR USE IN ELECTRONIC DEVICES MERCK PATENT GMBH (DE) 2023-08-23 EP disclosed
US-11329233-B2 Heterocyclic compounds for use in electronic devices MERCK PATENT GMBH (DE) 2022-05-10 US disclosed
US-20190296250-A1 HETEROCYCLIC COMPOUNDS FOR USE IN ELECTRONIC DEVICES MERCK PATENT GMBH (DE) 2019-09-26 US disclosed
WO-2018100029-A1 HETEROCYCLIC COMPOUNDS FOR USE IN ELECTRONIC DEVICES MERCK PATENT GMBH (DE) 2018-06-07 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20190296250-A1 HETEROCYCLIC COMPOUNDS FOR USE IN ELECTRONIC DEVICES NQO1, DDT, ETV6 L3MBTL1 3899/4885KDM4E 1555/4885ATM 4662/4885
US-11329233-B2 Heterocyclic compounds for use in electronic devices NQO1, DDT, ETV6 L3MBTL1 3899/4885KDM4E 1555/4885ATM 4662/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.